MariSubklewe Profile
MariSubklewe

@MSubklewe

Followers
838
Following
354
Media
11
Statuses
130

Interests: #AML,#Lymphoma, #Immunotherapy, #BiTE,#CART,#MRD

LMU-University Hospital Munich
Joined August 2020
Don't wanna be here? Send us removal request.
@MSubklewe
MariSubklewe
2 months
150+ women from all career stages came together at #FAME2025 – Females in Academic Medicine – at @LMU_Muenchen's Medical Faculty. A vibrant, strong space for exchange, inspiration & solidarity. Thanks to @WiebkeArlt, @AnnaFrebel & all who made it possible. #ConnectForChange
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
3
11
@MSubklewe
MariSubklewe
2 months
New in @BloodJournal: STING activation boosts CD33xCD3 mediated T cell cytotoxicity in #AML by creating an IFN-g- driven feedback loop. Happy to co-lead this with @VeitHornung, and kudos to first authors Andreas Linder & Daniel Nixdorf !
1
1
13
@MSubklewe
MariSubklewe
3 months
RT @JhaveriKhushali: 🚨Hot off the press 🚨.A lesser-known vulnerability in CAR T-cell therapy: Sarcopenia. New in CCR @AACR . Predicts ↑ NR….
0
5
0
@MSubklewe
MariSubklewe
3 months
RT @VJHemOnc: Don't miss our excellent interview from the #EBMT25 meeting earlier this week in which @MSubklewe of @LMU_Muenchen speaks on….
0
3
0
@MSubklewe
MariSubklewe
8 months
RT @LMU_Muenchen: 18 LMU scientists made the "#HighlyCitedResearchers 2024" list published by the analytics company @ClarivateAG, which pla….
0
7
0
@MSubklewe
MariSubklewe
1 year
Going beyond Cancer with T cell engagers: First-in-human report on a CD19 TCE for safe & successful treatment in systemic sclerosis. EJC in press. @OncologyAdvance.
1
8
33
@MSubklewe
MariSubklewe
1 year
RT @Springer_Med: How does the gut microbiome affect the efficacy of CAR T-cell therapy in patients with hematological malignancies? Prof.….
0
2
0
@MSubklewe
MariSubklewe
1 year
RT @ESHaematology: #ESHAL2024 Many thanks to @DombretHerve @Gossenkoppele Christoph Röllig @DrWendyStock for putting together such an excit….
0
1
0
@MSubklewe
MariSubklewe
2 years
Check out our @EHA_Hematology @TheEBMT consensus guidelines for a new distinct toxicity category of immune effector cell therapy (CAR-T, BsAb): ICAHT!. See link above for the accompanying commentary !. Also featured in the @BloodJournal podcast 👇.
1
8
32
@MSubklewe
MariSubklewe
2 years
RT @KRejeski: Great to see our @EHA_Hematology and @TheEBMT consensus guidelines article on immune effector cell-associated hematotoxicity….
0
24
0
@MSubklewe
MariSubklewe
2 years
RT @LMU_FAME: Professorinnen @LMU – gemeinsam für die neue Ära der Spitzenmedizin. Female professors @LMU_Uniklinikum - together for the ne….
0
13
0
@MSubklewe
MariSubklewe
2 years
RT @Kersten_MJ: @KRejeski @MSubklewe you made it to the icml highlights👍
Tweet media one
0
4
0
@MSubklewe
MariSubklewe
2 years
Kudos to the #EHA #EBMT team on putting together #ICAHT consensus guidelines now published in @BloodJournal. Grateful for this incredible European collaboration and a special shoutout to @KRejeski.
0
1
20
@MSubklewe
MariSubklewe
2 years
RT @KRejeski: Real honor to present our consensus grading and best practice recommendations for immune effector cell-associated hematotoxic….
0
30
0
@MSubklewe
MariSubklewe
2 years
Brilliant Habilitation Presentation by @KRejeski last nite at the LMU medical faculty colloquium. Congrats to this impressive publication track record - honored to be one of his mentors.
Tweet media one
2
1
38
@MSubklewe
MariSubklewe
2 years
RWE of EU & US practice patterns of Immune Effector Cell Associated Hematotoxicity (ICAHT) post #CART. Fantastic collaborative work with @EBMT @EHA and international #CAR community. Check out our survey @KRejeski @i_yakoub_agha @ annasureda5.
0
6
14
@MSubklewe
MariSubklewe
2 years
Filled with great joy & gratitude for an inspiring networking event of #FAME, a newly founded network of female university professors at the LMU Medical Faculty that fosters female careers and prepares the next generation of female leaders in academic medicine. Many more to come.
Tweet media one
Tweet media two
2
8
71
@MSubklewe
MariSubklewe
2 years
RT @gloria_iacoboni: Great to participate in this study aiming to identify infection vs CRS after #CART therapy, always a pleasure with @KR….
0
2
0
@MSubklewe
MariSubklewe
2 years
RT @VJHemOnc: #ISAL2023 | @MSubklewe of @LMU_Muenchen shares some insights into the current status of bispecifics in AML and challenges to….
0
2
0
@MSubklewe
MariSubklewe
2 years
RT @VJHemOnc: Next month, we'll be heading to #ISAL2023 to speak with experts who will bring you the latest in acute leukemias!. Find out m….
0
3
0